Clinical Trials Browser

Phase 2 × Neoplasms, Unknown Primary × 30 days × Clear all

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary